Medical Futures Innovation Awards 2011
The Consortium won two awards at the Medical Futures Innovation Awards 2011
MRC Translational Research Award & Best Therapeutic Innovation (Respiratory)
Viral Gene Therapy for Cystic Fibrosis Lung Disease
The Consortium's Lentiviral Gene Therapy Programme was nominated in the respiratory category for the 2011 Medical Futures Innovation Awards.
The Consortium won two awards:
- Best Therapeutic Innovation in the Respiratory Innovation Awards
- Best Translational Research Innovation
Browse this section to learn more about our lentiviral vector work and the award.
About the Medical Futures Awards
A Medical Futures Innovation Award is one of the UK's most sought after healthcare and business accolades, rewarding ground-breaking innovation from front line clinicians and scientists.
The reward recognises ideas that have the potential to transform peoples' lives and demonstrate the NHS and UK's position as a worldwide contender. The Awards cover a number of therapy areas from Cardiovascular Disease to Respiratory Disease. A unique element of these Awards is the unparalleled peer review and credibility that is brought to exciting early stage innovation and technologies.
They are judged by a panel of the most distinguished doctors and business leaders in the country. Experts such as Sir Bruce Keogh, Medical Director for the NHS; and Business Icon, Sir Anthony Jolliffe, come together as Europe's leading think-tank on healthcare innovation.
Information for Patients on Our Clinical Trial
Consortium Members' Internal Website
Medical Futures Innovation Award 2011